Labopharm files tramadol-acetaminophen drug in Europe

Labopharm (TSX:DDS) has initiated the regulatory approval process for its twice-daily tramadol-acetaminophen formulation in Europe under a decentralized procedure (DCP) system. “Initiating the regulatory approval process in Europe builds on our recently established marketing partnership with Grenenthal GmbH,” Labopharm CEO James Howard-Tripp said in a statement. “It is our intention to commercialize our twice-daily tramadol-acetaminophen [...]